Defining the Triple Negative Breast Cancer Kinome Response to GSK1120212.
Phase of Trial: Phase I
Latest Information Update: 16 Mar 2017
At a glance
- Drugs Trametinib (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- 18 Apr 2016 Status changed from recruiting to completed.
- 19 Nov 2013 Planned number of patients changed from 10 to 15 as reported by ClinicalTrials.gov.
- 19 Nov 2013 Planned end date changed from 1 Apr 2014 to 1 Dec 2016 as reported by ClinicalTrials.gov.